v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Sales, net of returns and allowances $ 3,028,545 $ 1,548,798 $ 8,688,423 $ 1,575,652
Cost of sales 6,557,358 9,515,547 20,312,854 16,459,102
Gross loss (3,528,813) (7,966,749) (11,624,431) (14,883,450)
Operating expenses        
Selling, general and administrative 11,756,291 34,753,017 40,448,651 59,693,419
Research and development 5,771,588 6,126,951 18,056,182 15,165,946
Total operating expenses 17,527,879 40,879,968 58,504,833 74,859,365
Loss from operations (21,056,692) (48,846,717) (70,129,264) (89,742,815)
Interest income (expense), net 410,980 27,716 1,466,839 (2,290,993)
Other income (loss) (10,000,000) 13,413,500 (10,000,000) 13,413,500
Loss before benefit for income taxes (30,645,712) (35,405,501) (78,662,425) (78,620,308)
Benefit for income taxes 0 0 0 0
Net loss $ (30,645,712) $ (35,405,501) $ (78,662,425) $ (78,620,308)
Net loss per share of common stock        
Basic (in usd per share) $ (0.14) $ (0.22) $ (0.41) $ (0.50)
Diluted (in usd per share) $ (0.14) $ (0.22) $ (0.41) $ (0.50)
Weighted average shares used in computing net loss per share of common stock        
Basic (in shares) 215,878,517 160,213,944 189,756,837 157,117,380
Diluted (in shares) 215,878,517 160,213,944 189,756,837 157,117,380

Source